Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
High Resolution Image Download MS PowerPoint Slide Neuronal Kv7 channels represent important pharmacological targets for hyperexcitability disorders including epilepsy. Retigabine is the prototype Kv7 activator clinically approved for seizure treatment; however, severe side effects associated with long-term use have led to its market discontinuation. Building upon the recently described cryoEM structure of Kv7.2 complexed with retigabine and on previous structure–activity relationship studies, a small library of retigabine analogues has been designed, synthesized, and characterized for their Kv7 opening ability using both fluorescence- and electrophysiology-based assays. Among all tested compounds, 60 emerged as a potent and photochemically stable neuronal Kv7 channel activator. Compared to retigabine, compound 60 displayed a higher brain/plasma distribution ratio, a longer elimination half-life, and more potent and effective anticonvulsant effects in an acute seizure model in mice. Collectively, these data highlight compound 60 as a promising lead compound for the development of novel Kv7 activators for the treatment of hyperexcitability diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Targeted Kv7 activation can stabilize VTA–nucleus accumbens (NAc) and prefrontal ensembles after induction, limit rebound hyperexcitability and extend benefit windows; dual-target constructs that couple Kv7.2/7.3 agonism with transient receptor potential vanilloid 1 (TRPV1) inhibition offer further resilience without added side effects [242,254,270].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [254]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the ventral hippocampus and ventral tegmental area (VTA), pharmacologic activation or genetic upregulation of potassium voltage-gated channel subfamily Q member 2 (Kcnq2) normalizes pathological firing and restores social interaction and anhedonia metrics; adjunct retigabine amplifies ketamine’s sustained benefits, linking intrinsic excitability control to durable antidepressant action [245,253”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [254]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the ventral hippocampus and ventral tegmental area (VTA), pharmacologic activation or genetic upregulation of potassium voltage-gated channel subfamily Q member 2 (Kcnq2) normalizes pathological firing and restores social interaction and anhedonia metrics; adjunct retigabine amplifies ketamine’s sustained benefits, linking intrinsic excitability control to durable antidepressant action [245,253”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [254]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Retigabine and newer derivatives can attenuate negative affect, reduce anxiety like states, and suppress maladaptive reward seeking, including cocaine self-administration, while supporting longer term stabilization of excitability [254,261,264].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [254]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9621760 · Cited by 15,409
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
OPM database and PPM web server: resources for positioning of proteins in membranes
Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I., & Lomize, A. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr703 · Cited by 2,151
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031
Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters
Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., et al. (2006) · ACM/IEEE SC 2006 Conference (SC'06) · doi:10.1109/sc.2006.54 · Cited by 1,673
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294
Beghi, E., Giussani, G., Nichols, E., Abd-Allah, F., Abdela, J., Abdelalim, A., Abraha, H. N., Adib, M. G., Agrawal, S., Alahdab, F., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30454-x · Cited by 1,036
Wei, A. D., Gutman, G. A., Aldrich, R., Chandy, K. G., Grissmer, S., & Wulff, H. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.9 · Cited by 978
Gutman, G. A., Chandy, K. G., Grissmer, S., Lazdunski, M., Mckinnon, D., Pardo, L. A., Robertson, G. A., Rudy, B., Sanguinetti, M. C., Stühmer, W., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.10 · Cited by 887
Scharfman, H. E. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0053-z · Cited by 523
A revised Racine's scale for PTZ-induced seizures in rats
Lüttjohann, A., Fabene, P. F., & van Luijtelaar, G. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.09.005 · Cited by 405 · cited 2×
“Seizures were scored using a 9-point scoring system modified from Lüttjohann’s scale (Lüttjohann et al., 2009).”
MethodMolecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant Retigabine
Schenzer, A., Friedrich, T., Pusch, M., Saftig, P., Jentsch, T. J., Grötzinger, J., & Schwake, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0128-05.2005 · Cited by 267
Wuttke, T. V., Seebohm, G., Bail, S., Maljevic, S., & Lerche, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010793 · Cited by 262
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
Rostock, A., Tober, C., Rundfeldt, C., Bartsch, R., Engel, J., Polymeropoulos, E. E., Kutscher, B., Löscher, W., Hönack, D., White, H. S., et al. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00101-8 · Cited by 240
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs
Miceli, F., Soldovieri, M. V., Martire, M., & Taglialatela, M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.003 · Cited by 176
Self-citationCatalytic Asymmetric Arylation of α-Aryl-α-diazoacetates with Aniline Derivatives
Xu, B., Li, M.-L., Zuo, X.-D., Zhu, S.-F., & Zhou, Q.-L. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05086 · Cited by 175
Weaver, C. D., Harden, D., Dworetzky, S. I., Robertson, B., & Knox, R. J. (2004) · SLAS Discovery · doi:10.1177/1087057104268749 · Cited by 171
Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels
Elinder, F., & Liin, S. I. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00043 · Cited by 166
Driving With No Brakes: Molecular Pathophysiology of Kv7 Potassium Channels
Soldovieri, M. V., Miceli, F., & Taglialatela, M. (2011) · Physiology · doi:10.1152/physiol.00009.2011 · Cited by 164
Self-citationMolecular basis for ligand activation of the human KCNQ2 channel
Li, X., Zhang, Q., Guo, P., Fu, J., Mei, L., Lv, D., Wang, J., Lai, D., Ye, S., Yang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00410-8 · Cited by 143
Zaczek, R., Chorvat, R. J., Saye, J. A., Pierdomenico, M. E., Maciag, C. M., Logue, A. R., Fisher, B. N., Rominger, D. H., & Earl, R. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37471-3 · Cited by 136
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction
Nappi, P., Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., & Taglialatela, M. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02404-2 · Cited by 123
Self-citationRundfeldt, C., & Netzer, R. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300346 · Cited by 116
Kalappa, B. I., Soh, H., Duignan, K. M., Furuya, T., Edwards, S., Tzingounis, A. V., & Tzounopoulos, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5176-14.2015 · Cited by 105
Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs
Li, T., Wu, K., Yue, Z., Wang, Y., Zhang, F., & Shen, H. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.10.037 · Cited by 92
Atomic basis for therapeutic activation of neuronal potassium channels
Kim, R. Y., Yau, M. C., Galpin, J. D., Seebohm, G., Ahern, C. A., Pless, S. A., & Kurata, H. T. (2015) · Nature Communications · doi:10.1038/ncomms9116 · Cited by 89
Photoinduced C(sp3)−N Bond Cleavage Leading to the Stereoselective Syntheses of Alkenes
Yang, Z., Xu, N., Wang, C., & Uchiyama, M. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201900886 · Cited by 81
Roeloffs, R., Wickenden, A. D., Crean, C. S., Werness, S., McNaughton-Smith, G. A., Stables, J. P., McNamara, J. O., Ghodadra, N., & Rigdon, G. C. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137794 · Cited by 69
New antiepileptic medication linked to blue discoloration of the skin and eyes
Clark, S., Antell, A., & Kaufman, K. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614560736 · Cited by 66
Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators
Kumar, M., Reed, N. L., Liu, R., Aizenman, E., Wipf, P., & Tzounopoulos, T. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103200 · Cited by 65
Cell-Based Potassium Ion Channel Screening Using the FluxOR™ Assay
Beacham, D. W., Blackmer, T., Grady, M. O., & Hanson, G. T. (2010) · SLAS DISCOVERY · doi:10.1177/1087057109359807 · Cited by 63
Groseclose, M. R., & Castellino, S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00313 · Cited by 62
Borlak, J. T., Gasparic, A., Locher, M., Schupke, H., & Hermann, R. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.006 · Cited by 58
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Taglialatela, M., Barrese, Miceli, Soldovieri, Ambrosino, Iannotti, & Cilio (2010) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s15369 · Cited by 50
Self-citationDiscovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate
Zhang, Y.-M., Xu, H.-Y., Hu, H.-N., Tian, F.-Y., Chen, F., Liu, H.-N., Zhan, L., Pi, X.-P., Liu, J., Gao, Z.-B., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02252 · Cited by 49
The anticonvulsant retigabine is a subtype selective modulator of GABAAreceptors
Treven, M., Koenig, X., Assadpour, E., Gantumur, E., Meyer, C., Hilber, K., Boehm, S., & Kubista, H. (2015) · Epilepsia · doi:10.1111/epi.12950 · Cited by 48
Bertamino, A., Ostacolo, C., Ambrosino, P., Musella, S., Sarno, V. D., Ciaglia, T., Soldovieri, M. V., Iraci, N., Fernández-Carvajal, A. M., de la Torre‐Martínez, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01914 · Cited by 48
Self-citationBierbower, S. M., Choveau, F. S., Lechleiter, J. D., & Shapiro, M. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-14.2015 · Cited by 43
Ostacolo, C., Miceli, F., Di Sarno, V., Nappi, P., Iraci, N., Soldovieri, M. V., Ciaglia, T., Ambrosino, P., Vestuto, V., Lauritano, A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00796 · Cited by 39
Self-citationThe ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator
Redford, K. E., & Abbott, G. W. (2020) · Communications Biology · doi:10.1038/s42003-020-1089-8 · Cited by 39
Sancineto, L., Iraci, N., Massari, S., Attanasio, V., Corazza, G., Barreca, M. L., Sabatini, S., Manfroni, G., Avanzi, N. R., Cecchetti, V., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300287 · Cited by 37
Self-citationGreene, D. L., Kosenko, A., & Hoshi, N. (2018) · Epilepsia · doi:10.1111/epi.14541 · Cited by 31
Oxidative cleavage of benzylic C–N bonds under metal-free conditions
Gong, J., Qi, X., Wei, D., Feng, J., & Wu, X. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01633e · Cited by 28
Douša, M., Srbek, J., Rádl, S., Černý, J., Klecán, O., Havlı́ček, J., Tkadlecová, M., Pekárek, T., Gibala, P., & Nováková, L. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.01.042 · Cited by 27
Sulfide Analogues of Flupirtine and Retigabine with Nanomolar KV7.2/KV7.3 Channel Opening Activity
Bock, C., Surur, A. S., Beirow, K., Kindermann, M. K., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900112 · Cited by 27
Characterization of a novel high-potency positive modulator of Kv7 channels
Dalby‐Brown, W., Jessen, C., Hougaard, C. Ø., Jensen, M. L., Jacobsen, T. A., Nielsen, K. S., Erichsen, H. K., Grunnet, M., Ahring, P. K., Christophersen, P., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.039 · Cited by 26
Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel
Shi, S., Li, J., Sun, F., Chen, Y., Pang, C., Geng, Y.-Z., Qi, J., Guo, S., Wang, X., Zhang, H., et al. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00113-6 · Cited by 21
Liu, R., Tzounopoulos, T., & Wipf, P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00097 · Cited by 19
Grupe, M., Bentzen, B. H., Benned-Jensen, T., Nielsen, V., Frederiksen, K., Jensen, H. S., Jacobsen, A.-M., Skibsbye, L., Sams, A. G., Grunnet, M., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173440 · Cited by 19
Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay
Li, Q., Rottländer, M., Xu, M.-K., Christoffersen, C. T., Frederiksen, K., Wang, M., & Jensen, H. S. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.06.040 · Cited by 18
Anticonvulsant effect of retigabine during postnatal development in rats
Forcelli, P. A., Soper, C., Lakhkar, A., Gale, K., & Kondratyev, A. D. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.03.006 · Cited by 18
Zhou, P., Zhang, Y., Xu, H., Chen, F., Chen, X., Li, X., Pi, X., Wang, L., Zhan, L., Nan, F., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095190 · Cited by 18
Identification and characterization of four process-related impurities in retigabine
Wang, X., Zhou, H., Zheng, J., Huang, C., Liu, W., Yu, L., & Zeng, S. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.07.035 · Cited by 15
Pérez, H. L., Boram, S. L., & Evans, C. A. (2015) · Analytical Methods · doi:10.1039/c4ay02599g · Cited by 10
Breidenbach, L., Hempel, K., Mittelstadt, S. W., & Lynch, J. J. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.106653 · Cited by 2
Research works printed but not linked: 6
- Zaczek R., 1998, J. Pharmacol. Exp. Ther., 285, 724
- 2020, Schrödinger Release 2020–1: Maestro
- 2020, Schrödinger Release 2020–1: LigPrep
- 2020, Schrödinger Release 2020–1: Glide
- 2019, Schrödinger Release 2019–1: Desmond Molecular Dynamics System
- 2019, Maestro-Desmond Interoperability Tools
Cited by
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Hu, T., Zhang, J., Wang, J., Sha, L., Xia, Y., Ortyl, T. C., Tian, X., & Chen, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01975 · Cited by 59
Targeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
“…[182], SCR2682 (4-(2-bromo-6,7-dihydrothieno[3, 2-c]pyridin-5(4H)- yl)−2,6-dimethylphenyl)−3,3-dimethylbutanamide) [183], ZM-003 [184], several resin acid derivatives [185], sulfide analogs of flupirtine and ezogabine [186], and other ezogabine derivatives [131].”
Self-citationSpecchio, N., Micco, V. D., Aronica, E., Auvin, S., Balestrini, S., Brunklaus, A., Gardella, E., Scheper, M., Taglialatela, M., Trivisano, M., et al. (2025) · Epilepsia · doi:10.1111/epi.18209 · Cited by 34
“109 Genetic variants in the sodium-and chloride-gated potassium channel KCNT1 cause severe, drug-resistant rare forms of early onset epilepsy such as epilepsy of infancy with migrating focal seizures; patients affected by KCNT1 - related encephalopathies also display developmental pla-teauing or…”
Self-citationWaris, A., Siraj, M., Khan, A. A., Lin, J., Asim, M., & Alhumaydhi, F. A. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00494 · Cited by 34
Wang, H., Qiao, Z., Luan, K., Xiang, W., Chang, X., Zhang, Y., Wei, N., & Wang, K. (2024) · Epilepsia · doi:10.1111/epi.18092 · Cited by 16
Metadata
- Authors
- Musella, S., Carotenuto, L., Iraci, N., Baroli, G., Ciaglia, T., Nappi, P., Basilicata, M. G., Salviati, E., Barrese, V., Vestuto, V., Pignataro, G., Pepe, G., Sommella, E., Di Sarno, V., Manfra, M., Campiglia, P., Gomez-Monterrey, I., Bertamino, A., Taglialatela, M., Ostacolo, C., & Miceli, F.
- Affiliations
- University of Salerno (IT)
- University of Naples Federico II (IT)
- University of Messina (IT)
- Department of Pharmacy, University of Salerno, Via G. Paolo II 132, Fisciano 84084, Salerno, Italy
- University of Basilicata (IT)
- Corresponding author
- Taglialatela, Maurizio
- Ostacolo, Carmine
- ORCID
- Musella, Simona
- Carotenuto, Lidia
- Iraci, Nunzio
- Ciaglia, Tania
- Basilicata, Manuela Giovanna
- Salviati, Emanuela
- Barrese, Vincenzo
- Vestuto, Vincenzo
- Pignataro, Giuseppe
- Pepe, Giacomo
- Sommella, Eduardo
- Manfra, Michele
- Campiglia, Pietro
- Gomez-Monterrey, Isabel
- Bertamino, Alessia
- Taglialatela, Maurizio
- Ostacolo, Carmine
- Miceli, Francesco
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-08-16
- Volume
- 65
- Issue
- 16
- Pages
- 11340-11364
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC9421656
- OpenAlex
- W4292004335
- Cited by
- 45
- References
- 61
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 13 · 2023: 4 · 2022: 3
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Basilicata) (submittedVersion, public-domain)
- Funders
- Ministero dell?Istruzione, dell?Universit? e della Ricerca (PRIN 2017ALCR7C, PRIN 2017YH3SXK, PRIN 2020L45ZW4)
- Universit? degli Studi di Napoli Federico II
- Compagnia di San Paolo
- Ministero della Salute (RF-2019-12370491)
- H2020 Health (825575, 875299)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Kv7 channels, antiepileptic drugs, epilepsy, structure-activity relationship, retigabine, elimination half-life, photostability, Kv7.2
- MeSH terms
- Animals, Anticonvulsants, Carbamates, Phenylenediamines, Seizures, Mice, KCNQ2 Potassium Channel, KCNQ3 Potassium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.